DOI: 10.1055/s-00023610

Drug Research

Referenz

O’Neil PM, Birkenfeld AL, McGowan B. et al.
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: A randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.

Lancet 2018;
392: 637-649

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in:
Aufrufen in: